15 mg to units tirzepatide Amble Units Dosing Chart Tirzepatide Dosage for Weight Loss

With compressed dosing, the GI effects can intensify temporarily

This guidance applies no matter the brand or formulation

Drug type Dual GIP/GLP-1 receptor agonist Active ingredient Tirzepatide (same as Zepbound/Mounjaro) FDA status Not FDA-approved (compounded) 2026 legality Narrow 503A patient-specific only Typical cost ~$125$449/mo, self-pay Looking for a prescription provider route

In adipose tissues, GIP (but not GLP-1) facilitates fat deposition

Furthermore, it has been proven to produce remarkable weight loss in obese people

Your healthcare provider may recommend anti-nausea medications or adjust your dosing schedule to improve tolerance